Myocardial scintigraphy gets boost in Denmark:
This article was originally published in Clinica
New guidelines for doctors on the use of myocardial scintigraphy in have been published by the Danish Society for Clinical Physiology and Nuclear Medicine. Although myocardial scintigraphy is still not widely used in Denmark compared with other European countries - its level of use is similar to Turkey, Portugal and the eastern European countries - it is becoming increasingly accepted as a useful technique for the diagnosis of ischaemic heart disease, according to the society. It is both cost-effective and patient-friendly and should be used more widely, the guidelines state.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.